Global Insulin Pen Market Growth Decelerates to 2.3% in 2020 due to COVID-19

The insulin delivery market has been negatively affected by the major upheavals experienced in diabetic care due to COVID-19. The insulin pen market which was seeing a compound annual growth rate (CAGR) of 5.1% prior to COVID-19 according to leading data and analytics company GlobalData has now decreased to show 2.3% growth in 2020 due to new patient start delays from physician office closings associated with COVID-19. Similar has been seen in the more traditional insulin pumps markets according to GlobalData a leading data and analytics company.

Tina Deng MSc Principal Medical Devices Analyst at GlobalData comments: “As people lose healthcare coverage due to unemployment in the pandemic some patients may choose cheaper alternatives to diabetes care products such as insulin vials. As the pricing of insulin pens has skyrocketed over the last several years in the US affordability may hammer device penetration during the COVID-19 crisis.”

COVID-19 not only causes life-threatening conditions for some patients with diabetes but also affects diabetic care globally.

Deng concludes: “As more medical facilities resumed their diabetic care services the insulin pen market is recuperating. Affordability programs from manufacturers for those who have been prescribed insulin pens can help increase access to these products. GlobalData expects the global insulin pen market to recover gradually by the end of 2020 or the beginning of 2021.”

Latest Press Release on Coronavirus News

Circadia Health, Cleveland Clinic Research Collaboration Shows Predictive Power of Continuous Respiratory Monitoring in Prediction of Clinical Deterioration in COVID-19

The study, conducted in collaboration with the Cleveland Clinic, demonstrates Circadia Health's C100 system's ability to offer continuous, contactless respiratory monitoring, predicting ...

Philips and AWS Collaborate to Scale Digital Pathology in the Cloud, Enhancing Diagnostic Capabilities and Improving Productivity

March 12, 2024 Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of c...

TRAWSFYNYDD THERAPEUTICS RECEIVES APPROVAL FOR THE FIRST PATIENT TRIAL OF TRX01, A ONCE-DAILY PROTEASE INHIBITOR FOR THE TREATMENT OF COVID 19

ROCKVILLE, Md. , Feb. 12, 2024 /PRNewswire/ -- Trawsfynydd Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering antiviral treatments for respirat...

Novel MRI Reveals Brain Changes in Long-COVID Patients

CHICAGO , Nov. 22, 2023 /PRNewswire/ -- People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to res...

New Treatment Restores Sense of Smell in Patients with Long COVID

CHICAGO , Nov. 20, 2023 /PRNewswire/ -- Using an image-guided minimally invasive procedure, researchers may be able to restore the sense of smell in patients who have suffered wit...